Publications – CECCARELLI LAB

1.

Anichini, A. et al. Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma. Preprint at https://doi.org/10.1101/2025.02.07.637045 (2025). Cite Download

1.

Floudas, C. S., Sarkizova, S., Ceccarelli, M. & Zheng, W. Leveraging mRNA technology for antigen based immuno-oncology therapies. J Immunother Cancer 13, e010569 (2025). Cite

1.

Scala, G. et al. MoNETA: MultiOmics Network Embedding for SubType Analysis. NAR Genomics and Bioinformatics 6, lqae141 (2024). Cite Download

1.

White, B. S. et al. Community assessment of methods to deconvolve cellular composition from bulk gene expression. Nat Commun 15, 7362 (2024). Cite

1.

Yan, F., Jiang, L., Chen, D., Ceccarelli, M. & Guo, Y. Reinventing gene expression connectivity through regulatory and spatial structural empowerment via principal node aggregation graph neural network. Nucleic Acids Research 52, e60–e60 (2024). Cite Download

1.

Yan, F., Jiang, L., Chen, D., Ceccarelli, M. & Guo, Y. Reinventing gene expression connectivity through regulatory and spatial structural empowerment via principal node aggregation graph neural network. Nucleic Acids Research 52, e60–e60 (2024). Cite

1.

Falco, M. et al. Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma. J Transl Med 22, 647 (2024). Cite

1.

Bertucci, F. et al. Mutational landscape of inflammatory breast cancer. J Transl Med 22, 374 (2024). Cite

1.

Wang, L. et al. Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm. PLoS ONE 19, e0299267 (2024). Cite Download

1.

Costa, M. C. et al. Identification of therapeutic targets in osteoarthritis by combining heterogeneous transcriptional datasets, drug-induced expression profiles, and known drug-target interactions. J Transl Med 22, 281 (2024). Cite Download

1.

Lofiego, M. F. et al. Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches. J Transl Med 22, 223 (2024). Cite Download

1.

Mason, M. et al. A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. J Transl Med 22, 190 (2024). Cite

1.

Cossu, A. M. et al. MiR-449a ANTAGONIZES EMT THROUGH IL-6-MEDIATED TRANS- SIGNALING IN LARYNGEAL SQUAMOUS CANCER. Molecular Therapy - Nucleic Acids 102140 (2024) http://doi.org/10.1016/j.omtn.2024.102140. Cite

1.

Petralia, F. et al. Pan-cancer proteogenomics characterization of tumor immunity. Cell S0092867424000643 (2024) http://doi.org/10.1016/j.cell.2024.01.027. Cite Download

1.

Feng, S. et al. Decomprolute is a benchmarking platform designed for multiomics-based tumor deconvolution. Cell Reports Methods 4, 100708 (2024). Cite

1.

Ramsoomair, C. K., Ceccarelli, M., Heiss, J. D. & Shah, A. H. The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses. J Transl Med 21, 893 (2023). Cite Download

1.

Ramsoomair, C. K., Ceccarelli, M., Heiss, J. D. & Shah, A. H. The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses. J Transl Med 21, 893 (2023). Cite

1.

Hu, L. S. et al. Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures. Nat Commun 14, 6066 (2023). Cite Download

1.

Hu, L. S. et al. Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures. Nat Commun 14, 6066 (2023). Cite

1.

Noviello, T. M. R. et al. Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. Nat Commun 14, 5914 (2023). Cite Download

1.

Mogenet, A. et al. Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer. J Transl Med 21, 637 (2023). Cite Download

1.

Jethalia, M., Jani, S. P., Ceccarelli, M. & Mall, R. Pancancer network analysis reveals key master regulators for cancer invasiveness. J Transl Med 21, 558 (2023). Cite Download

1.

Ferraro, L., Scala, G., Cerulo, L., Carosati, E. & Ceccarelli, M. MOViDA: multiomics visible drug activity prediction with a biologically informed neural network model. Bioinformatics 39, btad432 (2023). Cite Download

1.

Besharat, Z. M. et al. Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients. J Endocrinol Invest (2023) http://doi.org/10.1007/s40618-023-02115-2. Cite

1.

De Falco, A., Caruso, F., Su, X.-D., Iavarone, A. & Ceccarelli, M. A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data. Nature Communications 14, 1074 (2023). Cite Download

1.

Rosaria Noviello, T. M. et al. Guadecitabine plus Ipilimumab in Unresectable Melanoma: Five-Year Follow-up and Correlation with Integrated, Multiomic Analysis in the NIBIT-M4 Trial. http://medrxiv.org/lookup/doi/10.1101/2023.02.09.23285227 (2023) doi:10.1101/2023.02.09.23285227. Cite Download

1.

Migliozzi, S. et al. Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy. Nat Cancer (2023) http://doi.org/10.1038/s43018-022-00510-x. Cite Download

1.

Simeone, I. & Ceccarelli, M. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators. J Transl Med 21, 55 (2023). Cite Download

1.

McLaughlin, R. T. et al. Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning. npj Precis. Onc. 7, 4 (2023). Cite Download

1.

Feng, S. et al. Decomprolute: A Benchmarking Platform Designed for Multiomics-Based Tumor Deconvolution. http://biorxiv.org/lookup/doi/10.1101/2023.01.05.522902 (2023) doi:10.1101/2023.01.05.522902. Cite Download

1.

Wang, J. M. et al. Deep learning integrates histopathology and proteogenomics at a pan-cancer level. Cell Reports Medicine 101173 (2023) http://doi.org/10.1016/j.xcrm.2023.101173. Cite Download

1.

Liang, W.-W. et al. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell S1535610823002532 (2023) http://doi.org/10.1016/j.ccell.2023.07.013. Cite

1.

Li, Y. et al. Proteogenomic data and resources for pan-cancer analysis. Cancer Cell 41, 1397–1406 (2023). Cite Download

1.

Li, Y. et al. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell 186, 3921-3944.e25 (2023). Cite Download

1.

Geffen, Y. et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186, 3945-3967.e26 (2023). Cite Download

1.

Roelands, J. et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat Med 29, 1273–1286 (2023). Cite Download

1.

Di Giacomo, A. M. et al. Immunotherapy for brain metastases and primary brain tumors. European Journal of Cancer 179, 113–120 (2023). Cite

1.

Mason, M. et al. A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. http://biorxiv.org/lookup/doi/10.1101/2022.12.05.518667 (2022) doi:10.1101/2022.12.05.518667. Cite Download

1.

Anichini, A. et al. Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy. Journal of Experimental & Clinical Cancer Research 41, 325 (2022). Cite

1.

Sabato, C. et al. A novel microRNA signature for the detection of melanoma by liquid biopsy. J Transl Med 20, 469 (2022). Cite Download

1.

White, B. S. et al. Community Assessment of Methods to Deconvolve Cellular Composition from Bulk Gene Expression. http://biorxiv.org/lookup/doi/10.1101/2022.06.03.494221 (2022) doi:10.1101/2022.06.03.494221. Cite Download

1.

Federico, A. et al. Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study. Cancers 14, 2043 (2022). Cite Download

1.

Anichini, A. et al. Landscape of Immune-Related Signatures Induced by Targeting of Different Epigenetic Regulators in Melanoma: Implications for Immunotherapy. http://biorxiv.org/lookup/doi/10.1101/2022.04.13.488140 (2022) doi:10.1101/2022.04.13.488140. Cite Download

1.

Chan, S. et al. An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. Nat Cancer (2022) http://doi.org/10.1038/s43018-022-00334-9. Cite Download

1.

Simeone, I. et al. Prediction and pan-cancer analysis of mammalian transcripts involved in target directed miRNA degradation. Nucleic Acids Research 50, 2019–2035 (2022). Cite Download

1.

Sayaman, R. W. et al. Analytic pipelines to assess the relationship between immune response and germline genetics in human tumors. STAR Protocols 3, 101809 (2022). Cite

1.

D’Agostino, Y. et al. Loss of circadian rhythmicity in bdnf knock-out zebrafish larvae. iScience 104054 (2022) http://doi.org/10.1016/j.isci.2022.104054. Cite Download

1.

Saad, M. et al. Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study. The Lancet Oncology S147020452100752X (2022) http://doi.org/10.1016/S1470-2045(21)00752-X. Cite

1.

Bertucci, F. et al. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. J Immunother Cancer 10, e003687 (2022). Cite Download

1.

McLaughlin, R. T. et al. Attentive Deep Learning-Based Tumor-Only Somatic Mutation Classifier Achieves High Accuracy Agnostic of Tissue Type and Capture Kit. http://biorxiv.org/lookup/doi/10.1101/2021.12.07.471513 (2021) doi:10.1101/2021.12.07.471513. Cite Download